s-nitrosocaptopril has been researched along with Cells, Neoplasm Circulating in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Y; Gao, Y; Jia, L; Lian, S; Liang, H; Lu, Y; Xie, J; Xie, X; Ye, Y; Yu, S; Yu, T; Zhu, Y | 1 |
| Chen, S; Gao, Y; Jia, L; Liang, H; Lu, Y; Shao, J; Wang, J; Wang, L; Xie, J; Yu, S; Yu, T | 1 |
2 other study(ies) available for s-nitrosocaptopril and Cells, Neoplasm Circulating
| Article | Year |
|---|---|
S-Nitrosocaptopril prevents cancer metastasis in vivo by creating the hostile bloodstream microenvironment against circulating tumor cells.
Topics: Animals; Antineoplastic Agents; Blood Platelets; Captopril; Cell Adhesion; Cell Line, Tumor; Female; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasms; Neoplastic Cells, Circulating; P-Selectin; Platelet Glycoprotein GPIIb-IIIa Complex | 2019 |
Nitric oxide inhibits hetero-adhesion of cancer cells to endothelial cells: restraining circulating tumor cells from initiating metastatic cascade.
Topics: Captopril; Cell Adhesion; Cell Cycle; Cell Line, Tumor; Cell Survival; Cytokines; Endothelium, Vascular; Enzyme Inhibitors; Gene Expression; Guanylate Cyclase; Hemoglobins; Human Umbilical Vein Endothelial Cells; Humans; Neoplasm Metastasis; Neoplastic Cells, Circulating; Nitric Oxide; Nitric Oxide Donors; Vascular Cell Adhesion Molecule-1; Vasodilation | 2014 |